The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 5 - Clinical (3)

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

[P513] Valuable Interaction with Cognitive Remediation and Optimal Antipsychotics for Recovery in Schizophrenia (VICTORY-S): Study Protocol for an Interventional, Open-Label, Rater-Blinded, Randomized Comparison of Combined Treatment with Cognitive Remediation and Lurasidone or Paliperidone

*Ryotaro Kubota1, Satoru Ikezawa1,2, Hideki Oi3, Mari S Oba3, Shoki Izumi3, Leona Adachi1, Mako Miwa1, Ryoko Tsuno1, Shunji Toya4, Yohei Nishizato4, Daisuke Haga5, Tatsuro Iwane6, Kazuyuki Nakagome1 (1. Department of Psychiatry, National Center of Neurology and Psychiatry Hospital, Tokyo, Japan, 2. Department of Psychiatry, International University of Health and Welfare Mita Hospital, Tokyo, Japan, 3. Clinical Research and Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. CNS Group, Medical Science, Sumitomo Pharma Co., Ltd., Tokyo, Japan, 5. One More Job Training Institution, Toyonaka, Osaka, Japan, 6. Kyoto Prefectural Rakunan Hospital, Kyoto, Japan)

Keywords:schizophrenia, cognitive impairment, lurasidone, paliperidone, cognitive remediation

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password